Nazem Atassi

Summary

Affiliation: Massachusetts General Hospital
Country: USA

Publications

  1. pmc The PRO-ACT database: design, initial analyses, and predictive features
    Nazem Atassi
    From the Neurological Clinical Research Institute NCRI, Department of Neurology N A, J B, A Sherman, E S, J W, I K, M C, and the Biostatistics Center A Shui, D S, Massachusetts General Hospital, Boston and Prize4Life N Z, M L, Cambridge, MA
    Neurology 83:1719-25. 2014
  2. pmc A phase I, pharmacokinetic, dosage escalation study of creatine monohydrate in subjects with amyotrophic lateral sclerosis
    Nazem Atassi
    Neurology Clinical Trials Unit NCTU, Massachusetts General Hospital, 13th Street, Charlestown, MA 02129, USA
    Amyotroph Lateral Scler 11:508-13. 2010
  3. pmc Depression in amyotrophic lateral sclerosis
    Nazem Atassi
    Massachusetts General Hospital, Harvard Medical School, Boston, USA
    Amyotroph Lateral Scler 12:109-12. 2011
  4. pmc Advanced statistical methods to study the effects of gastric tube and non-invasive ventilation on functional decline and survival in amyotrophic lateral sclerosis
    Nazem Atassi
    Massachusetts General Hospital, Harvard Medical School, USA
    Amyotroph Lateral Scler 12:272-7. 2011
  5. pmc Pre-morbid type 2 diabetes mellitus is not a prognostic factor in amyotrophic lateral sclerosis
    Sabrina Paganoni
    Neurological Clinical Research Institute, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, USA
    Muscle Nerve 52:339-43. 2015
  6. doi request reprint Neuroprotective agents target molecular mechanisms of disease in ALS
    Yongjin Zhu
    Department of Neurosurgery, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
    Drug Discov Today 20:65-75. 2015
  7. pmc Increased in vivo glial activation in patients with amyotrophic lateral sclerosis: assessed with [(11)C]-PBR28
    Nicole R Zürcher
    A A Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA
    Neuroimage Clin 7:409-14. 2015
  8. pmc Diagnostic timelines and delays in diagnosing amyotrophic lateral sclerosis (ALS)
    Sabrina Paganoni
    Department of Neurology, Harvard Medical School, Neurological Clinical Research Institute NCRI, Massachusetts General Hospital, Boston, Massachusetts, USA
    Amyotroph Lateral Scler Frontotemporal Degener 15:453-6. 2014
  9. doi request reprint 7-T MRI of the spinal cord can detect lateral corticospinal tract abnormality in amyotrophic lateral sclerosis
    Julien Cohen-Adad
    AA Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, Massachusetts, USA
    Muscle Nerve 47:760-2. 2013
  10. pmc Feedback interaction of research, advocacy, and clinical care applied to ALS research in South America
    Miriam E Bucheli
    From the University of Massachusetts Medical School M E B, J S, Worcester San Francisco University of Quito A C, D C, C F, R L, Ecuador Wellesley College E D, MA and Massachusetts General Hospital N A, J D B, Harvard Medical School, Boston
    Neurology 81:1959-61. 2013

Collaborators

  • Hong Yu
  • Eric A Macklin
  • Eva Maria Ratai
  • Timothy M Miller
  • Xin Wang
  • Johnny Salameh
  • Julien Cohen-Adad
  • Sabrina Paganoni
  • Nicole R Zürcher
  • Yongjin Zhu
  • Merit E Cudkowicz
  • Merit Cudkowicz
  • James D Berry
  • Miriam E Bucheli
  • Marco L Loggia
  • Sarfraz Ahmad
  • Edward W Zhou
  • Jacob M Hooker
  • Anastasios Fotinos
  • Bruce R Rosen
  • Julia E Yasek
  • Lilly L J Mao
  • Robert Lawson
  • Yingjun Guan
  • Ciprian Catana
  • Peggy Allred
  • Matthew Harms
  • David Izquierdo-Garcia
  • David Schoenfeld
  • Jingxia Liu
  • Theodore Hyman
  • Oluwaseun Akeju
  • Nicholas Maragakis
  • Amy Shui
  • Daniel B Chonde
  • Amanda Zipf
  • Alexandra Lee
  • Judith Chang
  • Alyssa Murphy
  • Amelia Calderón
  • Carolina Franco
  • Ricardo Lopez
  • Diana Chicaiza
  • Elise Digga

Detail Information

Publications11

  1. pmc The PRO-ACT database: design, initial analyses, and predictive features
    Nazem Atassi
    From the Neurological Clinical Research Institute NCRI, Department of Neurology N A, J B, A Sherman, E S, J W, I K, M C, and the Biostatistics Center A Shui, D S, Massachusetts General Hospital, Boston and Prize4Life N Z, M L, Cambridge, MA
    Neurology 83:1719-25. 2014
    ..To pool data from completed amyotrophic lateral sclerosis (ALS) clinical trials and create an open-access resource that enables greater understanding of the phenotype and biology of ALS...
  2. pmc A phase I, pharmacokinetic, dosage escalation study of creatine monohydrate in subjects with amyotrophic lateral sclerosis
    Nazem Atassi
    Neurology Clinical Trials Unit NCTU, Massachusetts General Hospital, 13th Street, Charlestown, MA 02129, USA
    Amyotroph Lateral Scler 11:508-13. 2010
    ..Creatine appears to cross the blood-brain barrier, and oral administration of 15 g b.i.d. is associated with increased in vivo brain creatine concentrations and decreased glutamate concentrations...
  3. pmc Depression in amyotrophic lateral sclerosis
    Nazem Atassi
    Massachusetts General Hospital, Harvard Medical School, Boston, USA
    Amyotroph Lateral Scler 12:109-12. 2011
    ..In conclusion, major depression is less common in our ALS cohort than in the general population. The diagnosis of depression can be masked by some ALS related symptoms and it has no impact on enrollment in ALS clinical trials...
  4. pmc Advanced statistical methods to study the effects of gastric tube and non-invasive ventilation on functional decline and survival in amyotrophic lateral sclerosis
    Nazem Atassi
    Massachusetts General Hospital, Harvard Medical School, USA
    Amyotroph Lateral Scler 12:272-7. 2011
    ..G-tube placement could be followed by a faster rate of functional decline and increased mortality. Our results may suffer from some of the limitations of retrospective analyses...
  5. pmc Pre-morbid type 2 diabetes mellitus is not a prognostic factor in amyotrophic lateral sclerosis
    Sabrina Paganoni
    Neurological Clinical Research Institute, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, USA
    Muscle Nerve 52:339-43. 2015
    ..The aim of this study was to determine whether a history of pre-morbid type 2 diabetes mellitus (DM2) is a prognostic factor in amyotrophic lateral sclerosis (ALS)...
  6. doi request reprint Neuroprotective agents target molecular mechanisms of disease in ALS
    Yongjin Zhu
    Department of Neurosurgery, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
    Drug Discov Today 20:65-75. 2015
    ....
  7. pmc Increased in vivo glial activation in patients with amyotrophic lateral sclerosis: assessed with [(11)C]-PBR28
    Nicole R Zürcher
    A A Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA
    Neuroimage Clin 7:409-14. 2015
    ..Further studies will determine the role of [(11)C]-PBR28 as a marker of treatments that target neuroinflammation. ..
  8. pmc Diagnostic timelines and delays in diagnosing amyotrophic lateral sclerosis (ALS)
    Sabrina Paganoni
    Department of Neurology, Harvard Medical School, Neurological Clinical Research Institute NCRI, Massachusetts General Hospital, Boston, Massachusetts, USA
    Amyotroph Lateral Scler Frontotemporal Degener 15:453-6. 2014
    ..Older age, sporadic disease, and limb onset can delay ALS diagnosis...
  9. doi request reprint 7-T MRI of the spinal cord can detect lateral corticospinal tract abnormality in amyotrophic lateral sclerosis
    Julien Cohen-Adad
    AA Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, Massachusetts, USA
    Muscle Nerve 47:760-2. 2013
    ..Degeneration of the lateral corticospinal tract (CST) is a key finding in ALS cervical spinal cord autopsies. We hypothesized that in vivo ultra-high-field MRI of the cervical spinal cord can detect abnormality in the CST...
  10. pmc Feedback interaction of research, advocacy, and clinical care applied to ALS research in South America
    Miriam E Bucheli
    From the University of Massachusetts Medical School M E B, J S, Worcester San Francisco University of Quito A C, D C, C F, R L, Ecuador Wellesley College E D, MA and Massachusetts General Hospital N A, J D B, Harvard Medical School, Boston
    Neurology 81:1959-61. 2013
    ..This article discusses challenges for ALS research in South America (SA) and examines the ALS scientific record to explore the interactions and synergies of research, clinical care, and patient advocacy in underdeveloped regions. ..
  11. pmc Analysis of start-up, retention, and adherence in ALS clinical trials
    Nazem Atassi
    From the Neurological Clinical Research Institute, Department of Neurology N A, P Y R, H Y, M K, D G, J D, M L W, J S, A L, L J, M E C, and Biostatistics Center J S, E A M, Massachusetts General Hospital, Boston and Harvard Medical School N A, P Y R, E A M, M E C, Boston, MA
    Neurology 81:1350-5. 2013
    ..To investigate predictors of trial start-up times, high attrition, and poor protocol adherence in amyotrophic lateral sclerosis (ALS) trials...